ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,551Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 93

$433K Total Retail Price of All Prescriptions

Rank: 13 out of 93

334 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,022 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 434 416 1 4
OMEPRAZOLE 405 340 2 8
LEVOTHYROXINE SODIUM 362 338 3 5
GABAPENTIN 345 281 4 17
METOPROLOL TARTRATE 318 289 5 11
SIMVASTATIN 318 259 5 2
WARFARIN SODIUM 298 259 7 12
POTASSIUM CHLORIDE 241 231 8 13
RANITIDINE HCL 230 195 9 21
ATORVASTATIN CALCIUM 224 222 10 18
LOSARTAN POTASSIUM 220 216 11 26
TRAMADOL HCL 195 163 12 15
LISINOPRIL 188 137 13 3
HYDROCHLOROTHIAZIDE 164 134 14 10
METFORMIN HCL ER 154 130 15 99
AMLODIPINE BESYLATE 154 148 15 6
CARVEDILOL 135 123 17 23
METOPROLOL SUCCINATE 119 85 18 14
PAROXETINE HCL 111 101 19 64
OXYBUTYNIN CHLORIDE 99 77 20 95
METFORMIN HCL 96 66 21 7
FOSINOPRIL SODIUM 95 89 22 109
ALLOPURINOL 94 79 23 29
ALENDRONATE SODIUM 93 93 24 39
DOXAZOSIN MESYLATE 93 93 24 70
CHLORTHALIDONE 93 81 24 121
GLIPIZIDE 93 78 24 41
HYDROCODONE-ACETAMINOPHEN 85 66 S3 28 9
CITALOPRAM HBR 84 70 29 45
ENALAPRIL MALEATE 83 79 30 22
PRAVASTATIN SODIUM 80 65 31 20
CLOPIDOGREL 80 72 31 27
LABETALOL HCL 79 71 33 204
LEVOFLOXACIN 76 62 34 103
PREDNISONE 76 66 34 49
AMITRIPTYLINE HCL 75 40 R 36 61
TAMSULOSIN HCL 75 62 36 24
ZOLPIDEM TARTRATE 71 54 38 40
PLAVIX 68 63 39 44
GLIPIZIDE ER 67 67 40 56
DILTIAZEM 24HR CD 64 64 41 165
FAMOTIDINE 58 58 42 32
DIGOXIN 58 53 42 48
HYDRALAZINE HCL 58 51 42 73
CLONIDINE HCL 55 43 45 50
COMBIVENT 54 53 46 123
LOSARTAN-HYDROCHLOROTHIAZIDE 52 40 47 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.